AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer

Researchers presented results at the American Association for Cancer Research Annual Meeting showing that an artificial intelligence-driven algorithm using a liquid biopsy assay can differentiate women with ovarian cancer from healthy patients. The study found sensitivity rates ranging from 69% to 100% for different stages of ovarian cancer. The algorithm also had high specificity for detecting ovarian cancer and distinguishing between benign and malignant masses. While the study had limitations like a small sample size, researchers plan to validate their results in larger cohorts. The findings suggest a promising avenue for early detection and broad screening of ovarian cancer.

Source link

error: Content is protected !!